| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Graft Rejection | 68 | 2023 | 1065 | 12.700 |
Why?
|
| Transplantation Tolerance | 31 | 2023 | 130 | 8.440 |
Why?
|
| Organ Transplantation | 20 | 2023 | 265 | 7.640 |
Why?
|
| T-Lymphocytes | 46 | 2023 | 1195 | 6.730 |
Why?
|
| Skin Transplantation | 19 | 2023 | 172 | 5.410 |
Why?
|
| Graft Survival | 30 | 2023 | 885 | 5.060 |
Why?
|
| Heart Transplantation | 27 | 2023 | 705 | 4.120 |
Why?
|
| Transplantation Immunology | 12 | 2020 | 84 | 3.970 |
Why?
|
| Immune Tolerance | 22 | 2022 | 337 | 3.310 |
Why?
|
| CD4-Positive T-Lymphocytes | 22 | 2023 | 425 | 3.270 |
Why?
|
| Receptors, Antigen, T-Cell | 19 | 2018 | 371 | 3.130 |
Why?
|
| T-Lymphocytes, Regulatory | 11 | 2022 | 295 | 3.060 |
Why?
|
| Microbiota | 10 | 2023 | 381 | 3.050 |
Why?
|
| Isoantigens | 12 | 2023 | 66 | 2.840 |
Why?
|
| Lymphocyte Activation | 37 | 2018 | 728 | 2.820 |
Why?
|
| Immunoconjugates | 17 | 2016 | 106 | 2.490 |
Why?
|
| T-Lymphocyte Subsets | 13 | 2019 | 272 | 2.470 |
Why?
|
| Gastrointestinal Microbiome | 8 | 2023 | 456 | 2.450 |
Why?
|
| NF-kappa B | 14 | 2018 | 445 | 2.360 |
Why?
|
| Antigens, Differentiation | 18 | 2004 | 141 | 2.240 |
Why?
|
| Mice | 90 | 2023 | 11356 | 2.240 |
Why?
|
| Mice, Inbred C57BL | 53 | 2023 | 3095 | 2.240 |
Why?
|
| Animals | 117 | 2023 | 26590 | 2.200 |
Why?
|
| Mice, Inbred BALB C | 35 | 2023 | 1047 | 2.130 |
Why?
|
| Adaptive Immunity | 7 | 2021 | 164 | 1.960 |
Why?
|
| Transplantation, Homologous | 23 | 2023 | 996 | 1.910 |
Why?
|
| Isoantibodies | 7 | 2021 | 114 | 1.600 |
Why?
|
| Toll-Like Receptors | 7 | 2023 | 92 | 1.570 |
Why?
|
| Dendritic Cells | 7 | 2018 | 425 | 1.460 |
Why?
|
| Interferon-gamma | 9 | 2020 | 444 | 1.350 |
Why?
|
| Immunosuppressive Agents | 16 | 2020 | 977 | 1.350 |
Why?
|
| Allografts | 12 | 2023 | 172 | 1.290 |
Why?
|
| Signal Transduction | 23 | 2019 | 3243 | 1.280 |
Why?
|
| CD8-Positive T-Lymphocytes | 16 | 2019 | 558 | 1.180 |
Why?
|
| Skin | 5 | 2019 | 554 | 1.170 |
Why?
|
| Antigen Presentation | 3 | 2018 | 209 | 1.170 |
Why?
|
| B-Lymphocytes | 10 | 2021 | 724 | 1.150 |
Why?
|
| CD28 Antigens | 12 | 2011 | 88 | 1.110 |
Why?
|
| CARD Signaling Adaptor Proteins | 5 | 2018 | 15 | 1.080 |
Why?
|
| Antigen-Presenting Cells | 7 | 2019 | 139 | 1.050 |
Why?
|
| Immune System | 2 | 2014 | 93 | 0.930 |
Why?
|
| Biological Specimen Banks | 1 | 2023 | 65 | 0.890 |
Why?
|
| Immunity, Innate | 5 | 2020 | 409 | 0.890 |
Why?
|
| Bacterial Infections | 4 | 2014 | 182 | 0.880 |
Why?
|
| Bacteroidetes | 1 | 2023 | 37 | 0.880 |
Why?
|
| Glucose Intolerance | 1 | 2023 | 96 | 0.880 |
Why?
|
| Cell Differentiation | 10 | 2020 | 1458 | 0.870 |
Why?
|
| T-Lymphocytes, Cytotoxic | 7 | 2018 | 315 | 0.860 |
Why?
|
| Mice, Transgenic | 20 | 2021 | 1540 | 0.860 |
Why?
|
| Mice, Knockout | 24 | 2023 | 1924 | 0.830 |
Why?
|
| Hyperglycemia | 1 | 2023 | 176 | 0.830 |
Why?
|
| Transplantation | 2 | 2012 | 39 | 0.830 |
Why?
|
| Interleukin-17 | 3 | 2014 | 101 | 0.830 |
Why?
|
| Probiotics | 1 | 2023 | 81 | 0.820 |
Why?
|
| Staphylococcal Skin Infections | 3 | 2016 | 25 | 0.810 |
Why?
|
| Humans | 71 | 2023 | 86678 | 0.780 |
Why?
|
| CTLA-4 Antigen | 18 | 2016 | 135 | 0.760 |
Why?
|
| Reperfusion Injury | 3 | 2011 | 131 | 0.740 |
Why?
|
| Diet, High-Fat | 2 | 2023 | 114 | 0.740 |
Why?
|
| Salmonella Infections, Animal | 1 | 2019 | 11 | 0.700 |
Why?
|
| Congresses as Topic | 1 | 2020 | 116 | 0.700 |
Why?
|
| Kidney Transplantation | 4 | 2018 | 849 | 0.690 |
Why?
|
| Physical Conditioning, Animal | 1 | 2019 | 19 | 0.690 |
Why?
|
| B-Lymphocytes, Regulatory | 1 | 2019 | 8 | 0.680 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 76 | 0.670 |
Why?
|
| Organ Preservation | 1 | 2019 | 83 | 0.670 |
Why?
|
| Inflammation | 6 | 2023 | 923 | 0.660 |
Why?
|
| Tissue Donors | 3 | 2023 | 464 | 0.650 |
Why?
|
| Abatacept | 16 | 2006 | 83 | 0.640 |
Why?
|
| Cytomegalovirus Infections | 1 | 2019 | 144 | 0.630 |
Why?
|
| Calcineurin Inhibitors | 1 | 2018 | 54 | 0.610 |
Why?
|
| Antigens, CD | 19 | 2004 | 458 | 0.600 |
Why?
|
| Gastrointestinal Tract | 2 | 2020 | 191 | 0.590 |
Why?
|
| Adoptive Transfer | 10 | 2016 | 168 | 0.590 |
Why?
|
| Autoimmune Diseases | 3 | 2017 | 241 | 0.580 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2006 | 88 | 0.570 |
Why?
|
| Gene-Environment Interaction | 1 | 2017 | 103 | 0.560 |
Why?
|
| Forkhead Transcription Factors | 4 | 2019 | 166 | 0.550 |
Why?
|
| Clonal Deletion | 1 | 2015 | 23 | 0.520 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2019 | 36 | 0.520 |
Why?
|
| Interleukin-2 | 10 | 2022 | 249 | 0.520 |
Why?
|
| Thymus Gland | 4 | 2019 | 195 | 0.510 |
Why?
|
| Immunologic Memory | 6 | 2022 | 152 | 0.510 |
Why?
|
| Listeriosis | 5 | 2019 | 84 | 0.510 |
Why?
|
| Listeria monocytogenes | 5 | 2019 | 89 | 0.500 |
Why?
|
| Muromonab-CD3 | 7 | 2002 | 69 | 0.500 |
Why?
|
| Bacteria | 2 | 2019 | 447 | 0.490 |
Why?
|
| Obesity | 2 | 2023 | 964 | 0.490 |
Why?
|
| Kidney Failure, Chronic | 3 | 2018 | 509 | 0.490 |
Why?
|
| Corneal Transplantation | 1 | 2013 | 9 | 0.480 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2014 | 40 | 0.480 |
Why?
|
| Lung Transplantation | 2 | 2019 | 175 | 0.470 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2013 | 39 | 0.470 |
Why?
|
| Toll-Like Receptor 9 | 3 | 2014 | 20 | 0.470 |
Why?
|
| Interleukin-6 | 4 | 2018 | 256 | 0.460 |
Why?
|
| Antigens | 4 | 2022 | 228 | 0.460 |
Why?
|
| Receptors, Immunologic | 2 | 2011 | 135 | 0.460 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2014 | 302 | 0.450 |
Why?
|
| Communicable Diseases | 1 | 2014 | 63 | 0.450 |
Why?
|
| Neoplasms | 3 | 2017 | 2898 | 0.450 |
Why?
|
| Transplantation, Autologous | 1 | 2014 | 331 | 0.450 |
Why?
|
| Killer Cells, Natural | 4 | 2015 | 267 | 0.450 |
Why?
|
| Graft vs Host Disease | 2 | 2020 | 365 | 0.440 |
Why?
|
| Th17 Cells | 2 | 2012 | 80 | 0.440 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 2016 | 213 | 0.440 |
Why?
|
| B7-H1 Antigen | 4 | 2022 | 250 | 0.440 |
Why?
|
| Staphylococcus aureus | 6 | 2020 | 263 | 0.430 |
Why?
|
| Cytokines | 14 | 2011 | 778 | 0.420 |
Why?
|
| Graft vs Host Reaction | 1 | 2011 | 15 | 0.420 |
Why?
|
| Mice, Inbred C3H | 8 | 2012 | 370 | 0.420 |
Why?
|
| Transplants | 1 | 2012 | 40 | 0.410 |
Why?
|
| Antibodies, Bacterial | 3 | 2019 | 95 | 0.410 |
Why?
|
| Disease Models, Animal | 10 | 2020 | 2231 | 0.400 |
Why?
|
| Th1 Cells | 4 | 2004 | 164 | 0.400 |
Why?
|
| Th2 Cells | 4 | 2004 | 146 | 0.400 |
Why?
|
| Transgenes | 4 | 2015 | 180 | 0.380 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2012 | 225 | 0.380 |
Why?
|
| Female | 25 | 2023 | 44550 | 0.380 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2010 | 31 | 0.380 |
Why?
|
| Staphylococcal Infections | 3 | 2020 | 255 | 0.370 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1037 | 0.370 |
Why?
|
| I-kappa B Proteins | 3 | 2009 | 53 | 0.370 |
Why?
|
| Lymphocyte Subsets | 2 | 2010 | 64 | 0.370 |
Why?
|
| Trans-Activators | 3 | 2003 | 429 | 0.360 |
Why?
|
| fas Receptor | 2 | 2009 | 75 | 0.350 |
Why?
|
| Antibodies, Monoclonal | 12 | 2018 | 1376 | 0.350 |
Why?
|
| Treatment Outcome | 8 | 2020 | 7998 | 0.340 |
Why?
|
| Gene Expression Regulation | 6 | 2016 | 1921 | 0.340 |
Why?
|
| Antibody Formation | 2 | 2023 | 171 | 0.340 |
Why?
|
| Caspases | 1 | 2009 | 155 | 0.340 |
Why?
|
| Cell Cycle | 2 | 2009 | 502 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2009 | 189 | 0.330 |
Why?
|
| Spleen | 7 | 2016 | 430 | 0.320 |
Why?
|
| Langerhans Cells | 1 | 2007 | 13 | 0.320 |
Why?
|
| Antigens, Surface | 1 | 2008 | 101 | 0.310 |
Why?
|
| CD40 Ligand | 4 | 2023 | 69 | 0.310 |
Why?
|
| Flow Cytometry | 9 | 2011 | 679 | 0.310 |
Why?
|
| DNA-Binding Proteins | 7 | 2006 | 1208 | 0.310 |
Why?
|
| B7-1 Antigen | 7 | 2005 | 75 | 0.310 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2008 | 199 | 0.310 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2019 | 158 | 0.300 |
Why?
|
| DNA | 2 | 2014 | 1294 | 0.290 |
Why?
|
| H-2 Antigens | 3 | 2020 | 58 | 0.290 |
Why?
|
| Male | 17 | 2023 | 40988 | 0.290 |
Why?
|
| CD3 Complex | 6 | 2011 | 135 | 0.280 |
Why?
|
| Bifidobacterium | 2 | 2016 | 16 | 0.280 |
Why?
|
| Lymphocytes | 3 | 2020 | 464 | 0.280 |
Why?
|
| Adjuvants, Immunologic | 4 | 2023 | 167 | 0.280 |
Why?
|
| Anti-Bacterial Agents | 3 | 2016 | 747 | 0.280 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 532 | 0.270 |
Why?
|
| Taurodeoxycholic Acid | 2 | 2021 | 2 | 0.260 |
Why?
|
| Gene Expression | 2 | 2016 | 1284 | 0.250 |
Why?
|
| Peptides | 3 | 2023 | 639 | 0.250 |
Why?
|
| Valine | 2 | 2021 | 69 | 0.250 |
Why?
|
| Transcription Factors | 4 | 2022 | 1565 | 0.240 |
Why?
|
| I-kappa B Kinase | 5 | 2016 | 37 | 0.240 |
Why?
|
| Ovalbumin | 2 | 2022 | 109 | 0.230 |
Why?
|
| Immunity | 2 | 2022 | 136 | 0.230 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2022 | 878 | 0.230 |
Why?
|
| Ki-1 Antigen | 2 | 2002 | 17 | 0.230 |
Why?
|
| STAT5 Transcription Factor | 3 | 2014 | 42 | 0.230 |
Why?
|
| Lymphocyte Transfusion | 2 | 2019 | 41 | 0.230 |
Why?
|
| Cell Proliferation | 6 | 2019 | 1579 | 0.230 |
Why?
|
| Myeloid Differentiation Factor 88 | 4 | 2014 | 47 | 0.220 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2022 | 6 | 0.220 |
Why?
|
| Interleukin-13 | 1 | 2002 | 36 | 0.220 |
Why?
|
| Dysbiosis | 1 | 2023 | 70 | 0.220 |
Why?
|
| Melanoma | 2 | 2018 | 459 | 0.220 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2023 | 203 | 0.210 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2018 | 159 | 0.210 |
Why?
|
| Gene Targeting | 1 | 2002 | 72 | 0.210 |
Why?
|
| Skin Neoplasms | 2 | 2018 | 546 | 0.210 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2001 | 46 | 0.210 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2020 | 112 | 0.200 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 192 | 0.200 |
Why?
|
| Mice, Congenic | 2 | 2019 | 12 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 222 | 0.200 |
Why?
|
| CD4 Antigens | 2 | 2020 | 83 | 0.200 |
Why?
|
| Apoptosis | 5 | 2020 | 1683 | 0.200 |
Why?
|
| Postoperative Complications | 3 | 2020 | 2207 | 0.200 |
Why?
|
| Lymphocyte Count | 4 | 2016 | 94 | 0.200 |
Why?
|
| Administration, Oral | 1 | 2023 | 684 | 0.200 |
Why?
|
| src Homology Domains | 1 | 2001 | 44 | 0.200 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2021 | 11 | 0.200 |
Why?
|
| Gastrectomy | 1 | 2021 | 68 | 0.200 |
Why?
|
| Mice, SCID | 3 | 2000 | 252 | 0.190 |
Why?
|
| Metabolome | 1 | 2021 | 47 | 0.190 |
Why?
|
| Kinetics | 3 | 2016 | 1513 | 0.190 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2018 | 62 | 0.190 |
Why?
|
| Leukocytes | 3 | 2016 | 202 | 0.190 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2004 | 557 | 0.190 |
Why?
|
| Fatty Acids, Volatile | 1 | 2020 | 32 | 0.190 |
Why?
|
| Immunodominant Epitopes | 1 | 2020 | 19 | 0.190 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2014 | 41 | 0.180 |
Why?
|
| Graft Enhancement, Immunologic | 2 | 2000 | 13 | 0.180 |
Why?
|
| Germinal Center | 1 | 2020 | 55 | 0.180 |
Why?
|
| Major Histocompatibility Complex | 1 | 2020 | 81 | 0.180 |
Why?
|
| North America | 1 | 2020 | 180 | 0.180 |
Why?
|
| Fetus | 1 | 2021 | 226 | 0.180 |
Why?
|
| Staphylococcus epidermidis | 1 | 2019 | 14 | 0.180 |
Why?
|
| Societies, Medical | 2 | 2020 | 573 | 0.180 |
Why?
|
| Feces | 2 | 2018 | 319 | 0.180 |
Why?
|
| Europe | 1 | 2020 | 309 | 0.180 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 132 | 0.170 |
Why?
|
| Enterobacteriaceae | 1 | 2019 | 21 | 0.170 |
Why?
|
| Hepatocytes | 1 | 2020 | 127 | 0.170 |
Why?
|
| Salmonella typhimurium | 1 | 2019 | 32 | 0.170 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2019 | 8 | 0.170 |
Why?
|
| Immunoglobulin G | 2 | 2019 | 456 | 0.170 |
Why?
|
| Genes, Reporter | 1 | 2019 | 268 | 0.170 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2019 | 16 | 0.170 |
Why?
|
| Bacteriuria | 1 | 2018 | 10 | 0.170 |
Why?
|
| Soft Tissue Infections | 1 | 2019 | 26 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 879 | 0.170 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 57 | 0.170 |
Why?
|
| Obesity, Morbid | 1 | 2021 | 225 | 0.170 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 194 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 165 | 0.160 |
Why?
|
| Perfusion | 1 | 2019 | 203 | 0.160 |
Why?
|
| Guanylate Cyclase | 1 | 2018 | 18 | 0.160 |
Why?
|
| Urine | 1 | 2018 | 90 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 4 | 2002 | 1041 | 0.160 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 105 | 0.160 |
Why?
|
| Receptors, IgG | 2 | 1995 | 52 | 0.160 |
Why?
|
| Immunologic Techniques | 1 | 2017 | 27 | 0.160 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 231 | 0.160 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2018 | 87 | 0.160 |
Why?
|
| Mice, Inbred DBA | 4 | 2001 | 148 | 0.150 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 183 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 339 | 0.150 |
Why?
|
| Endocytosis | 3 | 2009 | 177 | 0.150 |
Why?
|
| Diet | 1 | 2020 | 443 | 0.150 |
Why?
|
| Proteins | 1 | 2002 | 777 | 0.150 |
Why?
|
| Sex Factors | 1 | 2020 | 1055 | 0.150 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2016 | 17 | 0.140 |
Why?
|
| Clindamycin | 1 | 2016 | 13 | 0.140 |
Why?
|
| Ligands | 3 | 2009 | 433 | 0.140 |
Why?
|
| Diet, Fat-Restricted | 1 | 2016 | 30 | 0.140 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2016 | 36 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 536 | 0.140 |
Why?
|
| Exosomes | 1 | 2016 | 50 | 0.140 |
Why?
|
| Liver | 2 | 2020 | 1230 | 0.130 |
Why?
|
| Genetic Engineering | 1 | 2016 | 114 | 0.130 |
Why?
|
| Immunotherapy | 2 | 2018 | 629 | 0.130 |
Why?
|
| Granzymes | 1 | 2015 | 93 | 0.130 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 67 | 0.130 |
Why?
|
| Body Weight | 1 | 2016 | 459 | 0.130 |
Why?
|
| Guanidines | 1 | 1994 | 31 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 269 | 0.120 |
Why?
|
| Immunity, Cellular | 2 | 2008 | 177 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 740 | 0.120 |
Why?
|
| Interleukin-7 | 1 | 2014 | 41 | 0.120 |
Why?
|
| Protein Kinases | 1 | 2015 | 209 | 0.120 |
Why?
|
| Young Adult | 3 | 2019 | 5980 | 0.120 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 103 | 0.120 |
Why?
|
| Kidney | 1 | 2020 | 1242 | 0.120 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2005 | 41 | 0.120 |
Why?
|
| Bacterial Vaccines | 1 | 2014 | 41 | 0.120 |
Why?
|
| Homeostasis | 2 | 2014 | 409 | 0.120 |
Why?
|
| B7-2 Antigen | 3 | 2003 | 40 | 0.120 |
Why?
|
| Blood Glucose | 2 | 2016 | 873 | 0.110 |
Why?
|
| Heart | 1 | 2016 | 539 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2012 | 6 | 0.110 |
Why?
|
| Time Factors | 6 | 2009 | 5214 | 0.110 |
Why?
|
| Recombination, Genetic | 1 | 2015 | 439 | 0.110 |
Why?
|
| Membrane Glycoproteins | 4 | 2004 | 428 | 0.110 |
Why?
|
| Cross-Priming | 1 | 2012 | 48 | 0.110 |
Why?
|
| B-Cell CLL-Lymphoma 10 Protein | 2 | 2009 | 8 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 78 | 0.110 |
Why?
|
| Lymphocyte Culture Test, Mixed | 4 | 2003 | 74 | 0.110 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2018 | 241 | 0.110 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1992 | 95 | 0.110 |
Why?
|
| STAT1 Transcription Factor | 1 | 2012 | 52 | 0.100 |
Why?
|
| Adolescent | 3 | 2016 | 8984 | 0.100 |
Why?
|
| Multiprotein Complexes | 2 | 2009 | 95 | 0.100 |
Why?
|
| Polymorphism, Genetic | 2 | 2009 | 819 | 0.100 |
Why?
|
| Clonal Anergy | 2 | 2009 | 30 | 0.100 |
Why?
|
| Transfection | 3 | 2002 | 896 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2012 | 250 | 0.100 |
Why?
|
| Enzyme Activation | 4 | 2009 | 692 | 0.100 |
Why?
|
| Transplantation, Heterotopic | 3 | 2010 | 45 | 0.100 |
Why?
|
| STAT4 Transcription Factor | 2 | 2001 | 10 | 0.100 |
Why?
|
| Injections, Intraperitoneal | 2 | 2021 | 102 | 0.100 |
Why?
|
| STAT6 Transcription Factor | 2 | 2001 | 28 | 0.100 |
Why?
|
| Clinical Trials as Topic | 2 | 2006 | 1169 | 0.100 |
Why?
|
| Risk Factors | 3 | 2018 | 5420 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 2 | 2008 | 36 | 0.090 |
Why?
|
| Cell Membrane | 4 | 2004 | 666 | 0.090 |
Why?
|
| Lymphopenia | 1 | 2010 | 28 | 0.090 |
Why?
|
| Antigens, Ly | 2 | 2009 | 37 | 0.090 |
Why?
|
| Chromatin | 1 | 2012 | 381 | 0.090 |
Why?
|
| RNA, Messenger | 5 | 2006 | 1981 | 0.090 |
Why?
|
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 1 | 2009 | 6 | 0.090 |
Why?
|
| Phenotype | 1 | 2016 | 2380 | 0.090 |
Why?
|
| Sarcoidosis | 1 | 2010 | 71 | 0.090 |
Why?
|
| Cell Line | 5 | 2018 | 2469 | 0.090 |
Why?
|
| Fas Ligand Protein | 1 | 2009 | 49 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2014 | 1196 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 864 | 0.090 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2008 | 9 | 0.090 |
Why?
|
| Receptors, Interleukin-2 | 3 | 2004 | 66 | 0.090 |
Why?
|
| Antigens, CD1d | 1 | 2009 | 29 | 0.080 |
Why?
|
| Oligonucleotides | 1 | 2009 | 92 | 0.080 |
Why?
|
| CD8 Antigens | 2 | 2006 | 82 | 0.080 |
Why?
|
| Antibodies | 3 | 2023 | 350 | 0.080 |
Why?
|
| Adult | 5 | 2019 | 25659 | 0.080 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2009 | 113 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2008 | 10 | 0.080 |
Why?
|
| Growth Inhibitors | 2 | 2004 | 41 | 0.080 |
Why?
|
| ROC Curve | 1 | 2010 | 752 | 0.080 |
Why?
|
| Cell Division | 4 | 2004 | 696 | 0.080 |
Why?
|
| bcl-X Protein | 2 | 2005 | 52 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2019 | 8496 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2016 | 2426 | 0.080 |
Why?
|
| Amino Acid Sequence | 7 | 1999 | 2062 | 0.080 |
Why?
|
| Cross Infection | 1 | 2009 | 141 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2018 | 506 | 0.080 |
Why?
|
| Immunization | 2 | 2001 | 158 | 0.080 |
Why?
|
| Mast Cells | 1 | 2007 | 92 | 0.080 |
Why?
|
| Epidermis | 1 | 2007 | 100 | 0.080 |
Why?
|
| Actins | 2 | 2016 | 451 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 246 | 0.080 |
Why?
|
| Calcinosis | 1 | 2008 | 224 | 0.070 |
Why?
|
| Leukemia, T-Cell | 1 | 2006 | 17 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2008 | 271 | 0.070 |
Why?
|
| Blood Platelets | 1 | 2007 | 149 | 0.070 |
Why?
|
| Cyclosporine | 1 | 2008 | 234 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2009 | 113 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2008 | 270 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 1995 | 1271 | 0.070 |
Why?
|
| Up-Regulation | 3 | 1998 | 715 | 0.070 |
Why?
|
| Receptor, Notch1 | 1 | 2006 | 85 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 322 | 0.070 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2006 | 20 | 0.070 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2006 | 29 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2008 | 782 | 0.070 |
Why?
|
| Genes, MHC Class I | 1 | 2006 | 48 | 0.070 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2005 | 5 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2004 | 75 | 0.070 |
Why?
|
| Neutrophils | 1 | 2007 | 307 | 0.070 |
Why?
|
| Disease Progression | 1 | 2010 | 1532 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1673 | 0.070 |
Why?
|
| Lymphocyte Depletion | 3 | 2010 | 97 | 0.070 |
Why?
|
| Colitis | 2 | 2019 | 239 | 0.070 |
Why?
|
| Molecular Sequence Data | 6 | 1998 | 3030 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 376 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2011 | 2819 | 0.060 |
Why?
|
| Splenomegaly | 1 | 2004 | 27 | 0.060 |
Why?
|
| Lymphoid Tissue | 1 | 2005 | 57 | 0.060 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2004 | 14 | 0.060 |
Why?
|
| Recombinant Proteins | 3 | 2014 | 1015 | 0.060 |
Why?
|
| Pregnancy | 2 | 2022 | 2894 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2008 | 669 | 0.060 |
Why?
|
| Cricetinae | 2 | 1995 | 560 | 0.060 |
Why?
|
| Mutation | 3 | 2012 | 3968 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 165 | 0.060 |
Why?
|
| Cell Death | 1 | 2004 | 256 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2004 | 144 | 0.060 |
Why?
|
| Tryptophan | 1 | 2003 | 90 | 0.060 |
Why?
|
| Middle Aged | 5 | 2019 | 25040 | 0.060 |
Why?
|
| Lymphatic System | 1 | 2003 | 53 | 0.060 |
Why?
|
| Lymph Nodes | 2 | 2005 | 533 | 0.060 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2002 | 6 | 0.060 |
Why?
|
| Immune Sera | 1 | 2002 | 52 | 0.050 |
Why?
|
| Microcirculation | 1 | 2003 | 106 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2004 | 193 | 0.050 |
Why?
|
| Cell Survival | 3 | 2014 | 969 | 0.050 |
Why?
|
| Arthritis, Psoriatic | 1 | 2002 | 32 | 0.050 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 86 | 0.050 |
Why?
|
| Abdomen | 1 | 2003 | 122 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 125 | 0.050 |
Why?
|
| Interferon-beta | 2 | 2014 | 125 | 0.050 |
Why?
|
| Aged | 4 | 2019 | 18423 | 0.050 |
Why?
|
| Cell Compartmentation | 2 | 1998 | 69 | 0.050 |
Why?
|
| Tumor Microenvironment | 2 | 2015 | 418 | 0.050 |
Why?
|
| Maximum Tolerated Dose | 1 | 2002 | 270 | 0.050 |
Why?
|
| Neoplasm Transplantation | 1 | 2002 | 391 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2004 | 580 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2021 | 44 | 0.050 |
Why?
|
| Models, Immunological | 1 | 2001 | 80 | 0.050 |
Why?
|
| Autoimmunity | 2 | 2018 | 160 | 0.050 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2001 | 19 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2016 | 305 | 0.050 |
Why?
|
| Interphase | 1 | 2001 | 34 | 0.050 |
Why?
|
| CD40 Antigens | 1 | 2001 | 43 | 0.050 |
Why?
|
| Base Sequence | 2 | 2015 | 2330 | 0.050 |
Why?
|
| Intracellular Fluid | 2 | 2000 | 34 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2003 | 790 | 0.050 |
Why?
|
| Graves Disease | 1 | 2000 | 36 | 0.050 |
Why?
|
| Pancreas | 1 | 2002 | 239 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2022 | 232 | 0.050 |
Why?
|
| Cloning, Molecular | 3 | 1998 | 646 | 0.050 |
Why?
|
| Exotoxins | 1 | 2020 | 20 | 0.050 |
Why?
|
| International Cooperation | 1 | 2020 | 127 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 6513 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 140 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 3642 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 696 | 0.040 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2019 | 9 | 0.040 |
Why?
|
| Freund's Adjuvant | 1 | 2019 | 26 | 0.040 |
Why?
|
| Global Health | 1 | 2020 | 193 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2001 | 303 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2019 | 74 | 0.040 |
Why?
|
| Calcium | 1 | 2004 | 1156 | 0.040 |
Why?
|
| Exons | 1 | 2000 | 450 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 1999 | 75 | 0.040 |
Why?
|
| Acute Disease | 1 | 2000 | 826 | 0.040 |
Why?
|
| Clone Cells | 1 | 1998 | 213 | 0.040 |
Why?
|
| Bifidobacterium longum | 1 | 2018 | 2 | 0.040 |
Why?
|
| Antigens, CD1 | 1 | 1998 | 35 | 0.040 |
Why?
|
| Vaccination | 1 | 2020 | 254 | 0.040 |
Why?
|
| Autoantigens | 1 | 2019 | 127 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 1995 | 131 | 0.040 |
Why?
|
| Adaptor Protein Complex mu Subunits | 1 | 1997 | 3 | 0.040 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 1997 | 6 | 0.040 |
Why?
|
| Histocompatibility | 1 | 2017 | 71 | 0.040 |
Why?
|
| Enterococcus faecium | 1 | 2018 | 32 | 0.040 |
Why?
|
| Intestines | 1 | 2001 | 411 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2018 | 122 | 0.040 |
Why?
|
| Plasma Cells | 1 | 2017 | 80 | 0.040 |
Why?
|
| Cell Movement | 1 | 2001 | 758 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2019 | 460 | 0.040 |
Why?
|
| Colon | 1 | 2020 | 496 | 0.040 |
Why?
|
| Models, Animal | 1 | 2017 | 263 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 186 | 0.040 |
Why?
|
| Jurkat Cells | 3 | 2003 | 77 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2016 | 62 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1457 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2018 | 206 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 615 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 1997 | 255 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 98 | 0.030 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1995 | 44 | 0.030 |
Why?
|
| Myocardium | 1 | 1998 | 529 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1995 | 104 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 973 | 0.030 |
Why?
|
| Integrases | 1 | 2015 | 59 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1995 | 109 | 0.030 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Genes, Immunoglobulin | 1 | 1995 | 111 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 307 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 123 | 0.030 |
Why?
|
| Nucleotidyltransferases | 1 | 2014 | 29 | 0.030 |
Why?
|
| Symbiosis | 1 | 2015 | 118 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2015 | 134 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 289 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1995 | 81 | 0.030 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2014 | 9 | 0.030 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2014 | 28 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 1997 | 503 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 88 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 1994 | 154 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1807 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2015 | 273 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2015 | 329 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1992 | 989 | 0.030 |
Why?
|
| Proteomics | 1 | 2015 | 211 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2013 | 80 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2011 | 1961 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1994 | 170 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2008 | 262 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 689 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 3 | 2000 | 42 | 0.030 |
Why?
|
| Rabbits | 1 | 2013 | 636 | 0.030 |
Why?
|
| Binding Sites, Antibody | 1 | 1992 | 49 | 0.030 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1992 | 12 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 1992 | 38 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2006 | 268 | 0.030 |
Why?
|
| Receptors, Fc | 1 | 1992 | 33 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 1992 | 683 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 2011 | 66 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 1802 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 3680 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 171 | 0.020 |
Why?
|
| Antigens, CD19 | 1 | 2010 | 39 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 4214 | 0.020 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2009 | 10 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 194 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2009 | 67 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 301 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2009 | 83 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2008 | 94 | 0.020 |
Why?
|
| Bystander Effect | 1 | 2008 | 12 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2008 | 26 | 0.020 |
Why?
|
| Protein Kinase C-theta | 1 | 2008 | 16 | 0.020 |
Why?
|
| Hemolysin Proteins | 1 | 2008 | 34 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2008 | 71 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2008 | 54 | 0.020 |
Why?
|
| Rats | 1 | 1994 | 3992 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 111 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 411 | 0.020 |
Why?
|
| Interferon Type I | 1 | 2008 | 175 | 0.020 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2006 | 12 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 2006 | 15 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2008 | 207 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 179 | 0.020 |
Why?
|
| Bortezomib | 1 | 2006 | 76 | 0.020 |
Why?
|
| COS Cells | 1 | 2006 | 166 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2006 | 55 | 0.020 |
Why?
|
| Pyrazines | 1 | 2006 | 92 | 0.020 |
Why?
|
| Transcription Factor RelB | 1 | 2005 | 7 | 0.020 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2005 | 29 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2005 | 49 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2006 | 267 | 0.020 |
Why?
|
| Succinimides | 1 | 2004 | 13 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2004 | 43 | 0.020 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2004 | 5 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2004 | 14 | 0.020 |
Why?
|
| Cats | 2 | 1995 | 304 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2004 | 29 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2004 | 303 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2004 | 29 | 0.020 |
Why?
|
| Tryptophan Oxygenase | 1 | 2003 | 8 | 0.010 |
Why?
|
| Ion Transport | 1 | 2004 | 81 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2004 | 63 | 0.010 |
Why?
|
| Hair Follicle | 1 | 2003 | 26 | 0.010 |
Why?
|
| GATA3 Transcription Factor | 1 | 2003 | 48 | 0.010 |
Why?
|
| Cation Transport Proteins | 1 | 2004 | 64 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 393 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2004 | 129 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 371 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2006 | 1538 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 242 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 425 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 286 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1753 | 0.010 |
Why?
|
| Jejunum | 1 | 2001 | 79 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2002 | 321 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1384 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 916 | 0.010 |
Why?
|
| Adenine | 1 | 2000 | 85 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 544 | 0.010 |
Why?
|
| Solubility | 1 | 2000 | 177 | 0.010 |
Why?
|
| Hypertension | 1 | 2008 | 1142 | 0.010 |
Why?
|
| Guanine | 1 | 2000 | 208 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 1999 | 9 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 1999 | 13 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 1999 | 24 | 0.010 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1999 | 33 | 0.010 |
Why?
|
| Tyrosine | 1 | 1999 | 133 | 0.010 |
Why?
|
| Gamma Rays | 1 | 1998 | 72 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2004 | 568 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1998 | 155 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1998 | 129 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1998 | 290 | 0.010 |
Why?
|
| Receptor Aggregation | 1 | 1997 | 3 | 0.010 |
Why?
|
| Epitopes | 1 | 1998 | 255 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 1749 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1997 | 49 | 0.010 |
Why?
|
| Alleles | 1 | 2000 | 1128 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1998 | 253 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1999 | 379 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1999 | 1106 | 0.010 |
Why?
|
| Binding Sites | 1 | 1999 | 1098 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 1998 | 352 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1999 | 645 | 0.010 |
Why?
|
| Macrophages | 1 | 1998 | 557 | 0.010 |
Why?
|
| Biological Assay | 1 | 1993 | 78 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1993 | 256 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1993 | 416 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1992 | 23 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1992 | 44 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1992 | 145 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 173 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1992 | 86 | 0.010 |
Why?
|